Exton PA, US, 16 Feb 2016 16:00 CET
Royal DSM, a global science-based company active in health, nutrition and materials, today announces Mr. Eric Teutsch’s appointment as President of DSM Biomedical effective 16 February 2016. Mr. Teutsch succeeds Mr. Gerard de Reuver who served as the Company’s interim president since November 2015.
As president, Mr. Teutsch will oversee the strategic development and execution of DSM Biomedical’s global activities. Under his leadership, DSM Biomedical will continue to strengthen existing technology platforms and will explore opportunities to form strategic partnerships that complement its activities in the medical device market.
“I am honored to have been appointed President of DSM Biomedical,” said Mr. Teutsch. “The Company has a proven track record of developing innovative solutions for the medical device market and I am excited to drive expansion and solidify our position as the market leader.”
Mr. Teutsch joins DSM from Stryker, where he was Vice President and General Manager of the Orthobiologics Division. In his nearly 30 years at Stryker, Teutsch led the acquisition, integration and operation of ten new product lines and businesses and led four new stand-alone business divisions. He has a proven track record in building and developing highly engaged global leadership teams that consistently gained market share and met or exceeded sales and profit goals.